Serum levels of des-gamma-carboxy prothrombin measured using the revised enzyme immunoassay kit with increased sensitivity in relation to clinicopathologic features of solitary hepatocellular carcinoma.
Hiroaki Okuda(Tokyo Women's Medical University), Masayuki Nakano(Nihon University), Akiko Saito(Tokyo Women's Medical University), Kazuko Takatsu(Tokyo Women's Medical University), Naoaki Hayashi(Kyoto University), Toshimi Nakanishi(Tokyo Women's Medical University), Masakazu Yamamoto(Tokyo Women's Medical University), Ken Takasaki(Tokyo Women's Medical University), Kazuyuki Takenami(Tokyo Women's Medical University)
PubMed
February 1, 2000
Cited by 90
Related Papers
Randomized clinical trial of adjuvant gemcitabine chemotherapy <i>versus</i> observation in resected bile duct cancer
|British journal of surgery|2018|401
Imaging Study of Early Hepatocellular Carcinoma: Usefulness of Gadoxetic Acid–enhanced MR Imaging
|Radiology|2011|354
cHCC‐CCA
|Hepatology|2018|333
Clinical aspects of intrahepatic bile duct carcinoma including hilar carcinoma.A study of 57 autopsy-proven cases
|Cancer|1977|262
Perivenular Fibrosis in Alcoholic Liver Injury: Ultrastructure and Histologic Progression
|Gastroenterology|1982|249